Companies

UNITED GUARDIAN INC

UG · CIK 0000101295 · operating

$6.50-1.37%Last updated Mar 4, 8:56 PM

Key Statistics

Valuation

Market Cap$29.86M
P/E15.12
Fwd P/E
PEG
P/S2.97
P/B2.82
EV/EBITDA9.88
EV/Rev2.14

Profitability

Gross Margin
Op. Margin
Net Margin
ROE27.36%
ROA23.56%
FCF Margin

Financial Health

Current Ratio6.62
Debt/Equity0.16
Free Cash Flow$3.03M
Div. Yield7.69%

Growth & Other

Revenue Growth
EPS Growth
Beta1.00
52W High$10.29
52W Low$5.58

About UNITED GUARDIAN INC

United Guardian develops and manufactures specialty chemical products for cosmetic, pharmaceutical, and medical applications. The company's core offering is LUBRAJEL, a proprietary hydrogel platform used as a multifunctional ingredient in personal care formulations, medical devices, and pharmaceutical preparations. Related products include B-122, a powdered lubricant for pressed cosmetics and industrial use, and LUBRASIL II SB, a silicone-enhanced variant. The company also markets ORCHID COMPLEX, an oil-based botanical extract for cosmetic applications.

The pharmaceutical segment includes RENACIDIN, a prescription product for catheter calcification management, and CLORPACTIN WCS-90, a chlorine-based topical antimicrobial used primarily in urology. Medical applications for Lubrajel formulations span catheter lubrication, medical device coating, condom lubrication, and oral care products. The company's sexual wellness segment offers hydrogel-based ingredient lines marketed under the Natrajel brand, designed to provide lubrication, moisturization, and sensory properties.

United Guardian operates as a small-scale manufacturer with 24 full-time employees and is headquartered in Hauppauge, New York. The company distributes products domestically and internationally, serving cosmetic manufacturers, pharmaceutical companies, medical device makers, and consumer wellness brands as ingredient suppliers and direct manufacturers.

Earnings Per Share (Annual · SEC XBRL)

Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.

Fiscal YearEPS DilutedEPS BasicYoY
2024$0.71+26.8%
2023$0.56+0.0%
2022$0.56
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011

Annual Reports (10-K) · 18 filings

Report DateFiledAccession Number
2024-12-312025-03-210001171843-25-001611SEC ↗
2023-12-312024-03-220001171843-24-001526SEC ↗
2022-12-312023-03-230001171843-23-001846SEC ↗
2021-12-312022-03-230001171843-22-002061SEC ↗
2020-12-312021-03-220001171843-21-001963SEC ↗
2019-12-312020-03-260001171843-20-002021SEC ↗
2018-12-312019-03-210001171843-19-001878SEC ↗
2017-12-312018-03-220001171843-18-002183SEC ↗
2016-12-312017-03-230001171843-17-001709SEC ↗
2015-12-312016-03-240001171843-16-008781SEC ↗
2014-12-312015-03-260001171843-15-001673SEC ↗
2013-12-312014-03-240001171843-14-001385SEC ↗
2012-12-312013-03-210001171843-13-001097SEC ↗
2011-12-312012-03-260001171843-12-001021SEC ↗
2010-12-312011-03-250001171843-11-000851SEC ↗
2009-12-312010-03-250001171843-10-000469SEC ↗
2008-12-312009-03-240001171843-09-000269SEC ↗
2007-12-312008-03-270000101295-08-000004SEC ↗